Enalare Therapeutics: Funding, Investors & Team (Sep 2026)
Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical organization devoted to creating and commercializing novel treatments for patients experiencing intense respiratory and basic consideration conditions including respiratory melancholy brought about by drug glut, post-medical procedure, and microorganisms.
Enalare Therapeutics has raised $11.0M across 5 funding rounds on record, the most recent an undisclosed round announced in Sep 2024.
Enalare Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2024.
Enalare Therapeutics Funding Rounds
2 of 5 rounds were announced without a disclosed amount and are excluded from the total.
Enalare Therapeutics raised $10.0M in a Seed announced in Feb 2021.
1 years later, a Debt Financing of $1.0M was announced in Feb 2022.
5 months later, a Grant was announced in Jul 2022 with no disclosed amount.
7 months later, an undisclosed round of $30k was announced in Feb 2023.
1.6 years later, an undisclosed round was announced in Sep 2024 with no disclosed amount.
Enalare Therapeutics Founders and Leadership Team
Contact details for the Enalare Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Enalare Therapeutics Funding Compared to Other Biotechnology Startups
Funded Startups Like Enalare Therapeutics in Biotechnology and Naples
Companies Similar to Enalare Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Enalare Therapeutics Funding FAQs
What does Enalare Therapeutics do?
Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical organization devoted to creating and commercializing novel treatments for patients experiencing intense respiratory and basic consideration conditions including respiratory melancholy brought about by drug glut, post-medical procedure, and microorganisms.
How much funding has Enalare Therapeutics raised?
Enalare Therapeutics has raised $11.0M across 5 rounds on record.
When did Enalare Therapeutics last raise funding?
Enalare Therapeutics' most recent funding round on record was announced in Sep 2024. The amount was not disclosed.
Who is the CEO of Enalare Therapeutics?
Herm Cukier is listed as CEO at Enalare Therapeutics.
Where is Enalare Therapeutics headquartered?
Enalare Therapeutics is based in Naples, Florida, United States.
How many employees does Enalare Therapeutics have?
Enalare Therapeutics is in the 1-10 employee band.
About FundedIQ's Enalare Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Enalare Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.